title: Biopsy as well as FibroTest/Fibrosure is suboptimal for discriminating intermediate fibrosis stages in patients with chronic hepatitis B.
authors.affiliation: BioPredictive, Paris, France.
authors.forename: Mona
authors.initials: M
authors.lastname: Munteanu
authors.affiliation: BioPredictive, Paris, France.
authors.forename: Marion
authors.initials: M
authors.lastname: Houot
authors.affiliation: BioPredictive, Paris, France.
authors.forename: Yen
authors.initials: Y
authors.lastname: Ngo
authors.affiliation: BioPredictive, Paris, France.
authors.forename: Thierry
authors.initials: T
authors.lastname: Poynard
mesh_terms: D015415:Biomarkers / Q000097:blood*; D019694:Hepatitis B, Chronic / Q000150:complications*; D006801:Humans; D008099:Liver / Q000473:pathology*; D008103:Liver Cirrhosis / Q000175:diagnosis*; D008111:Liver Function Tests
chemical_list: D015415:Biomarkers